铜绿假单胞菌氨基糖苷修饰基因新突变的分子和计算见解。

IF 2.5 4区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Huma Jalil, Khadija Shams, Asad Ullah, Ibrar Khan, Sajjad Ahmad, Ayesha Saleem, Kalsoom Khan, Muhammad Salim, Syed Ainul Abideen, Mohammad Abdullah Aljasir, Muhammad Irfan
{"title":"铜绿假单胞菌氨基糖苷修饰基因新突变的分子和计算见解。","authors":"Huma Jalil, Khadija Shams, Asad Ullah, Ibrar Khan, Sajjad Ahmad, Ayesha Saleem, Kalsoom Khan, Muhammad Salim, Syed Ainul Abideen, Mohammad Abdullah Aljasir, Muhammad Irfan","doi":"10.1007/s12033-025-01508-3","DOIUrl":null,"url":null,"abstract":"<p><p>The production of aminoglycoside-modifying genes by P. aeruginosa is one of the key mechanisms by which resistance to aminoglycoside antibiotics is developed. The aim of the present work was to examine the prevalence of aac(6)-Ib, aac(6)-IIa, and aac(3)-IIa aminoglycoside-modifying genes in clinical samples. A total of 500 clinical samples were collected from Khyber Teaching Hospital (KTH), and showed a prevalence of 43.8% for P. aeruginosa. The biochemical identification of isolates was performed by Analytical Profile Index kit (API 20E) and on molecular level by PCR for the OprL gene. The antibiotic susceptibility pattern of the identified isolates was determined by the following guidelines of Clinical and Laboratory Standards Institute (CLSI), 2021. The results revealed that 121 out of 219 P. aeruginosa isolates were resistant to aminoglycosides. The frequencies of aac(6)-Ib, aac(3)-IIa and aac(6)-IIa were 95, 71.9, and 60.33%, respectively. Among the aminoglycoside-resistant isolates, 41.32% showed the presence of all the three genes. After sequencing of the PCR products, mutations were detected in aac(6)-Ib (Q110H), aac(3)-IIa (W5F, M51T, M58K, G63S) and aac(6)-IIa (T75P, G89S). The mutated sequence was translated into a protein sequence, followed by the prediction of its structure. After structure prediction, the binding ability of the wild and mutated proteins was analyzed through molecular docking. The docking analysis calculated different binding energy scores of -7.6, -7.1, -8.3, -7.1, and -7.1 kcal/mol for the aac(6)-Ib wild protein and antibiotics, including Gentamicin, Tobramycin, Amikacin, Kanamycin, and Streptomycin, respectively. In the case of mutated proteins and antibiotics, binding energies of -6.8, -6.1, -7.3, -6, and -5.6 kcal/mol were calculated. The dynamic stability of the docked complex was examined using molecular dynamics simulations, and the results indicate that the docked complexes maintain their stability throughout the simulation time frame.</p>","PeriodicalId":18865,"journal":{"name":"Molecular Biotechnology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Molecular and Computational Insights of Novel Mutations in Aminoglycoside-Modifying Genes of P. aeruginosa.\",\"authors\":\"Huma Jalil, Khadija Shams, Asad Ullah, Ibrar Khan, Sajjad Ahmad, Ayesha Saleem, Kalsoom Khan, Muhammad Salim, Syed Ainul Abideen, Mohammad Abdullah Aljasir, Muhammad Irfan\",\"doi\":\"10.1007/s12033-025-01508-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The production of aminoglycoside-modifying genes by P. aeruginosa is one of the key mechanisms by which resistance to aminoglycoside antibiotics is developed. The aim of the present work was to examine the prevalence of aac(6)-Ib, aac(6)-IIa, and aac(3)-IIa aminoglycoside-modifying genes in clinical samples. A total of 500 clinical samples were collected from Khyber Teaching Hospital (KTH), and showed a prevalence of 43.8% for P. aeruginosa. The biochemical identification of isolates was performed by Analytical Profile Index kit (API 20E) and on molecular level by PCR for the OprL gene. The antibiotic susceptibility pattern of the identified isolates was determined by the following guidelines of Clinical and Laboratory Standards Institute (CLSI), 2021. The results revealed that 121 out of 219 P. aeruginosa isolates were resistant to aminoglycosides. The frequencies of aac(6)-Ib, aac(3)-IIa and aac(6)-IIa were 95, 71.9, and 60.33%, respectively. Among the aminoglycoside-resistant isolates, 41.32% showed the presence of all the three genes. After sequencing of the PCR products, mutations were detected in aac(6)-Ib (Q110H), aac(3)-IIa (W5F, M51T, M58K, G63S) and aac(6)-IIa (T75P, G89S). The mutated sequence was translated into a protein sequence, followed by the prediction of its structure. After structure prediction, the binding ability of the wild and mutated proteins was analyzed through molecular docking. The docking analysis calculated different binding energy scores of -7.6, -7.1, -8.3, -7.1, and -7.1 kcal/mol for the aac(6)-Ib wild protein and antibiotics, including Gentamicin, Tobramycin, Amikacin, Kanamycin, and Streptomycin, respectively. In the case of mutated proteins and antibiotics, binding energies of -6.8, -6.1, -7.3, -6, and -5.6 kcal/mol were calculated. The dynamic stability of the docked complex was examined using molecular dynamics simulations, and the results indicate that the docked complexes maintain their stability throughout the simulation time frame.</p>\",\"PeriodicalId\":18865,\"journal\":{\"name\":\"Molecular Biotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Biotechnology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12033-025-01508-3\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12033-025-01508-3","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

P. aeruginosa产生氨基糖苷修饰基因是氨基糖苷类抗生素产生耐药性的关键机制之一。本研究的目的是检测临床样本中aac(6)-Ib、aac(6)-IIa和aac(3)-IIa氨基糖苷修饰基因的患病率。从开伯尔教学医院(KTH)采集临床样本500份,铜绿假单胞菌感染率为43.8%。采用API 20E试剂盒对分离株进行生化鉴定,并在分子水平上对OprL基因进行PCR鉴定。鉴定菌株的抗生素敏感性模式根据临床和实验室标准协会(CLSI) 2021年的指导方针确定。结果显示,219株铜绿假单胞菌中有121株对氨基糖苷类耐药。aac(6)-Ib、aac(3)-IIa和aac(6)-IIa的频率分别为95.5%、71.9%和60.33%。在氨基糖苷耐药菌株中,41.32%的菌株同时存在上述3个基因。PCR产物测序后,在aac(6)-Ib (Q110H)、aac(3)-IIa (W5F、M51T、M58K、G63S)和aac(6)-IIa (T75P、G89S)中检测到突变。突变序列被翻译成蛋白质序列,然后预测其结构。在进行结构预测后,通过分子对接分析野生蛋白与突变蛋白的结合能力。对接分析计算出aac(6)-Ib野生蛋白与抗生素(包括庆大霉素、托布霉素、阿米卡星、卡那霉素和链霉素)的结合能得分分别为-7.6、-7.1、-8.3、-7.1和-7.1 kcal/mol。在突变蛋白和抗生素的情况下,计算出-6.8,-6.1,-7.3,-6和-5.6 kcal/mol的结合能。通过分子动力学模拟考察了对接物的动力学稳定性,结果表明对接物在整个模拟时间内保持稳定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Molecular and Computational Insights of Novel Mutations in Aminoglycoside-Modifying Genes of P. aeruginosa.

The production of aminoglycoside-modifying genes by P. aeruginosa is one of the key mechanisms by which resistance to aminoglycoside antibiotics is developed. The aim of the present work was to examine the prevalence of aac(6)-Ib, aac(6)-IIa, and aac(3)-IIa aminoglycoside-modifying genes in clinical samples. A total of 500 clinical samples were collected from Khyber Teaching Hospital (KTH), and showed a prevalence of 43.8% for P. aeruginosa. The biochemical identification of isolates was performed by Analytical Profile Index kit (API 20E) and on molecular level by PCR for the OprL gene. The antibiotic susceptibility pattern of the identified isolates was determined by the following guidelines of Clinical and Laboratory Standards Institute (CLSI), 2021. The results revealed that 121 out of 219 P. aeruginosa isolates were resistant to aminoglycosides. The frequencies of aac(6)-Ib, aac(3)-IIa and aac(6)-IIa were 95, 71.9, and 60.33%, respectively. Among the aminoglycoside-resistant isolates, 41.32% showed the presence of all the three genes. After sequencing of the PCR products, mutations were detected in aac(6)-Ib (Q110H), aac(3)-IIa (W5F, M51T, M58K, G63S) and aac(6)-IIa (T75P, G89S). The mutated sequence was translated into a protein sequence, followed by the prediction of its structure. After structure prediction, the binding ability of the wild and mutated proteins was analyzed through molecular docking. The docking analysis calculated different binding energy scores of -7.6, -7.1, -8.3, -7.1, and -7.1 kcal/mol for the aac(6)-Ib wild protein and antibiotics, including Gentamicin, Tobramycin, Amikacin, Kanamycin, and Streptomycin, respectively. In the case of mutated proteins and antibiotics, binding energies of -6.8, -6.1, -7.3, -6, and -5.6 kcal/mol were calculated. The dynamic stability of the docked complex was examined using molecular dynamics simulations, and the results indicate that the docked complexes maintain their stability throughout the simulation time frame.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Biotechnology
Molecular Biotechnology 医学-生化与分子生物学
CiteScore
4.10
自引率
3.80%
发文量
165
审稿时长
6 months
期刊介绍: Molecular Biotechnology publishes original research papers on the application of molecular biology to both basic and applied research in the field of biotechnology. Particular areas of interest include the following: stability and expression of cloned gene products, cell transformation, gene cloning systems and the production of recombinant proteins, protein purification and analysis, transgenic species, developmental biology, mutation analysis, the applications of DNA fingerprinting, RNA interference, and PCR technology, microarray technology, proteomics, mass spectrometry, bioinformatics, plant molecular biology, microbial genetics, gene probes and the diagnosis of disease, pharmaceutical and health care products, therapeutic agents, vaccines, gene targeting, gene therapy, stem cell technology and tissue engineering, antisense technology, protein engineering and enzyme technology, monoclonal antibodies, glycobiology and glycomics, and agricultural biotechnology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信